BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3493944)

  • 21. Prognostic significance of cell surface markers in childhood acute lymphoblastic leukaemia.
    Kumar S; Carr TF; Evans DI; Morris-Jones P; Hann IM
    Clin Lab Haematol; 1979; 1(2):121-8. PubMed ID: 317037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surface markers of T and B lymphocytes: II. Their investigation in 13 patients with untreated acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Dec; 102(12):689-93. PubMed ID: 7022076
    [No Abstract]   [Full Text] [Related]  

  • 23. The study of T-, B-, O- lymphocytes in acute lymphoblastic leukemia.
    Bogusławska-Jaworska J; Chybicka A
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):859-66. PubMed ID: 312091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The T lymphoblastic malignancies.
    Nadler LM; Reinherz EL; Schlossman SF
    Cancer Chemother Pharmacol; 1980; 4(1):11-5. PubMed ID: 6988098
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute lymphoblastic leukemia: classification and characterization with antisera to human T-cell and Ia antigens.
    Anderson JK; Moore JO; Falletta JM; Terry WF; Metzgar RS
    J Natl Cancer Inst; 1979 Feb; 62(2):293-8. PubMed ID: 310908
    [No Abstract]   [Full Text] [Related]  

  • 26. Phenotypic characterization of 'non-T, non-B' acute lymphoblastic leukemia by a new panel (BL) of monoclonal antibodies.
    Al-Katib A; Wang CY; Bardales R; Koziner B
    Hematol Oncol; 1985; 3(4):271-81. PubMed ID: 2417929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute lymphoblastic leukemia polymorphism disclosed by monoclonal antibodies.
    Leglise MC; Desfontaine B; Abgrall JF; Dutel JL; Le Roux AM; Vicariot M; Briere J
    Ric Clin Lab; 1984; 14(3):313-8. PubMed ID: 6335284
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression of HLA-DR alloantigens on acute lymphoblastic leukemia lymphoblasts.
    Orgad S; Yunis EJ; Zaizov R; Ramot B; Altshuler R; Gazit E
    Hum Immunol; 1984 Feb; 9(2):67-74. PubMed ID: 6421779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface markers in human lymphoid leukaemias.
    Nadkarni JJ; Nadkarni JS; Advani SH
    Indian J Cancer; 1978 Dec; 15(4):43-7. PubMed ID: 317270
    [No Abstract]   [Full Text] [Related]  

  • 30. The great majority of childhood lymphoblastic leukaemias are identified by monoclonal antibodies as neoplasias of the B-cell progenitor compartment.
    Melsom H; Funderud S; Lie SO; Godal T
    Scand J Haematol; 1984 Jul; 33(1):27-34. PubMed ID: 6611581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of central nervous system irradiation in children with lymphoblastic leukemia on lymphocyte subpopulations and leukocyte migration inhibition indicators in the peripheral blood].
    Cesarz-Kruz E; Lukas A; Sroczyńska M; Lukas W; Sońta-Jakimczyk D
    Pediatr Pol; 1981 Sep; 56(9):1003-7. PubMed ID: 6976551
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lymphoblastic leukemia and immunological markers].
    Ifrah N; Perrot JY; Marie JP; Boasson M; Zittoun R
    Ann Med Interne (Paris); 1987; 138(7):527-32. PubMed ID: 3326452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The periodic acid-Schiff reaction and prognosis in children with acute lymphoblastic leukemia.
    Raney RB; Festa RS; Waldman MT; Manson D; Hann HW
    Am J Hematol; 1979; 6(1):27-34. PubMed ID: 313153
    [No Abstract]   [Full Text] [Related]  

  • 34. [T and B-lymphocytes in acute lymphoblastic leukemia of childhood at diagnosis and during the initial stages of therapy (author's transl)].
    De Martino M; Biagioli EC; Pisanu C; Lippi A; Novembre E; Guazzelli C; Vierucci A
    Haematologica; 1979 Aug; 64(4):442-54. PubMed ID: 121579
    [No Abstract]   [Full Text] [Related]  

  • 35. Morphologic, cytochemical and immunological profile in T-cell acute lymphoblastic leukemia of childhood.
    Cantù-Rajnoldi A; Cattoretti G; Schirò R; Ferrari M; Guercilena S; Belforti S; Masera G
    Haematologica; 1986; 71(6):467-72. PubMed ID: 3104155
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunological diagnosis of acute lymphoblastic leukemia].
    Shalaev VA
    Gematol Transfuziol; 1986 Jun; 31(6):51-5. PubMed ID: 3525320
    [No Abstract]   [Full Text] [Related]  

  • 37. Utility of monoclonal antibodies in the immunologic phenotyping of acute lymphoblastic leukemia.
    Yu AL; Royston I; Leung KL; Kung FH; Hartman GA; Lightsey AL; Vangrove J; Sobol RE
    Hybridoma; 1982; 1(2):91-8. PubMed ID: 6985381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunodiagnosis of childhood ALL: problems associated with the use of peripheral blood alone.
    Lauer SJ; Casper JT; Borella LD
    Med Pediatr Oncol; 1979; 6(2):157-62. PubMed ID: 313504
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cytochemical characteristics and immunologic markers in acute lymphoblastic leukemias (author's transl)].
    Dorlhiac P; Genter G; Jamra M
    Sangre (Barc); 1981; 26(4):433-8. PubMed ID: 6974901
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of monoclonal antibodies and molecular biology technics in the immunological classification of acute lymphoblastic leukemias].
    Chen Z; Sigaux F
    Pathol Biol (Paris); 1986 Jan; 34(1):5-7. PubMed ID: 2939390
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.